Automation index
How much of a Quality engineer’s job can AI already do?
An FMEA and an 8D come earlier. Stopping the supplier and deciding if the batch travels do not.
This percentage does not predict how many people will lose their jobs.
Task comparison
IS WORK OVER?
Quality engineer
29%
AI can already do 29% of this job.
#63 / 643
View rankingQuality engineer
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
FMEA, control plan and the limits.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
8D, claims and the supplier.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Audit, IATF and the awkward finding.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
The line, the defect and stop or not.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 18% | +3.2 |
APQP, PPAP and the customer launch.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
Release with judgement, and not hiding the PPM.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 14% | +2.2 |
| Total | 100% | 28% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- FMEA
- 8D
- control plan
- IATF
- PPAP
- APQP
- supplier claims
- release batches
Sources for this job· O*NET 17-2112.00· ESCO/ISCO 2141
IS WORK OVER?
Immunologist
27%
#168 / 643
View rankingImmunologist
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Panel, autoantibodies and the report.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Clinic, the flare and the one that does not fit.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Immunosuppressant, the dose and not dropping extra.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Infection, the risk and vaccinating on time.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The internist, the board and not delaying the biologic.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Call it autoimmune, and sign the treatment.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- autoantibodies
- autoimmune flares
- immunosuppressants
- biologics
- vaccinate the immunocompromised
- immunology clinic
- opportunistic infections
- immune panels
Sources for this job· O*NET 29-1229.00· ESCO/ISCO 2212